EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of cytokines in ovarian cancer drug resistance

Lu Wang, Yunxia Zang, Rebeka Dejenie, Junyuan Bing, Shixia Dong, Yanfei Zhang, Yi Zhu, Jingjing Li

International Journal of Cancer · 15.02.2026 · 158 (4) · 821-834

DOI: 10.1002/ijc.70099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 19.09.2025. Verfasst von Lu Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Shandong Second Medical University, Weifang, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Ovarian Neoplasms, Cytokines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Project jointly established by the Science and Technology Department of the State Administration of Traditional Chinese Medicine, Shandong Provincial Key Medical and Health Discipline of Oncology (Affiliated Hospital of Shandong Second Medical University), Shandong Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer is the leading cause of death among women diagnosed with female reproductive system cancers. While significant advances have been made in treating various types of cancer, progress in ovarian cancer treatment over the past 20 years has been minimal, and the treatment course of ovarian cancer is not linear. Although many patients initially respond to treatment and may experience tumor regression, 80% of patients relapse after one or multiple chemotherapy sessions. Cytokines play a crucial role in driving tumor progression, relapse, and drug resistance in ovarian cancer. The knowledge of ovarian cancer drug resistance and the function of cytokines in the development of tumor resistance is currently the subject of numerous relevant studies; meanwhile, the specific molecular pathways are being unearthed. Herein, we summarize the recent advancements in cytokine‐associated ovarian cancer drug resistance. In addition, we also present the cytokine targeting drugs in ameliorating ovarian cancer drug resistance. As multi‐effect factors, cytokines can induce multiple pathways to promote tumor progression and overcome extremely complex and heterogeneous living environments. From the perspective of various paths of cytokine function, the emergence of multi‐target drugs might be more promising for conquering ovarian cancer chemotherapy drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmOvarian NeoplasmsCytokinesHumansFemaleAnimalsAntineoplastic AgentsTumor Microenvironment

Stichwörter der Autor:innen

IL6cytokinedrug resistanceovarian cancertumor microenvironment

Substanzen

CytokinesAntineoplastic Agents

Autor:innen und Institutionen

  • School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
  • Jinming Yu Academician Workstation of Oncology, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
  • Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
  • University of Chicago Medical Center, Chicago, Illinois, USA.
  • Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Orthopaedic Institute, Medical College, Soochow University, Suzhou, China.

Förderung

  • Science and Technology Project jointly established by the Science and Technology Department of the State Administration of Traditional Chinese Medicine
  • Shandong Provincial Key Medical and Health Discipline of Oncology (Affiliated Hospital of Shandong Second Medical University)
  • Shandong Provincial Health Commission
  • National Natural Science Foundation of China
  • Yuandu Scholar Grant of Weifang City to LJJ, Science and Technology Innovation Plan from Weifang Medical University
  • Weifang Science and Technology Bureau Plan Project
  • Shandong Provincial Medical Association Young Talent Promotion Project
  • Weifang Key Laboratory of Biomimetic Diagnostics

Zitieren

APA

Wang, L., Zang, Y., Dejenie, R., Bing, J., Dong, S., Zhang, Y., Zhu, Y., & Li, J. (2026). The role of cytokines in ovarian cancer drug resistance. International Journal of Cancer, 158(4), 821-834. https://doi.org/10.1002/ijc.70099

Vancouver

Wang L, Zang Y, Dejenie R, Bing J, Dong S, Zhang Y, et al. The role of cytokines in ovarian cancer drug resistance. International Journal of Cancer. 2026;158(4):821-834. doi:10.1002/ijc.70099

BibTeX
@article{Wang2026,
  author = {Wang, Lu and Zang, Yunxia and Dejenie, Rebeka and Bing, Junyuan and Dong, Shixia and Zhang, Yanfei and Zhu, Yi and Li, Jingjing},
  title = {The role of cytokines in ovarian cancer drug resistance},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {158},
  number = {4},
  pages = {821--834},
  doi = {10.1002/ijc.70099}
}
Kostenlos starten →